![Lori Firmani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lori Firmani
Geen lopende functies
Vermogen: 23 163 $ op 31-05-2026
Profiel
Lori Firmani worked as Chief Financial & Accounting Officer at F-Star Therapeutics, Inc. in 2020.
Ms. Firmani worked as Chief Financial & Accounting Officer at Damora Therapeutics, Inc. from 2024 to 2026.
Ms. Firmani earned an MBA from Babson College and completed undergraduate studies at the State University of New York College at Geneseo.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 22-04-2026 | 931 ( 0% ) | 23 163 $ | 31-05-2026 |
Eerdere bekende functies van Lori Firmani
| Bedrijven | Functie | Einde |
|---|---|---|
| DAMORA THERAPEUTICS, INC. | Financieel Directeur/CFO | 01-05-2026 |
| SPRING BANK PHARMACEUTICALS, INC. | Financieel Directeur/CFO | 20-11-2020 |
Opleiding van Lori Firmani
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
14
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Babson College
 Babson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
State University of New York College at Geneseo
 State University of New York College at Geneseo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F-Star Therapeutics, Inc. (United States)
 F-Star Therapeutics, Inc. (United States) Pharmaceuticals: MajorHealth Technology Engages in discovery, development and preparation of bioavailable therapeutics | Health Technology |
Galecto, Inc.
 Galecto, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for treatment of severe diseases | Health Technology |
